Account

Industry resources and insights

Sort by year
  • All time
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017 and older
Articles
01.06.2023
Digital health applications in EU5 market access

We explore the rapidly evolving market access landscape in respect to digital health applications in...

Read more
Articles
23.05.2023
How has the COVID-19 pandemic impacted the use of ...

Digital health technology played a vital role during the COVID-19 pandemic as there was a rapid usag...

Read more
Newsletter
17.05.2023
PMA Insights: Week 20 SPECIAL EDITION – ISPO...

We summarise ISPOR Annual 2023 including plenary sessions on artificial intelligence, real-world evi...

Read more
Publications
10.05.2023
ISPOR US 2023: Plenary Session 2 – AI wants ...

Our experts provide a detailed summary of Plenary Session 2 at ISPOR Annual 2023 on artificial intel...

Read more
Publications
09.05.2023
ISPOR US 2023: Plenary Session 1 – Global Fo...

Our experts provide a detailed summary of Plenary Session 1 at ISPOR Annual 2023 on global affordabi...

Read more
Insider Insights
05.05.2023
HAS issues favorable reimbursement opinion

This is the first time that HAS is issuing a favorable opinion for the reimbursement of a technology...

Read more
Load more
Browse by topic
  • Biosimilars
  • Devices & Diagnostics
  • Digital Health
  • Early Access
  • Early Payer Dialogue
  • Emerging & Developing Markets
  • Funding
  • Gene Therapy & ATMPs
  • HTA
  • International Reference Pricing
  • Launch
  • Managed Entry Agreements
  • NICE
  • Oncology
  • Orphan Drugs
  • PMA Trends
  • Pricing
  • Rare Diseases
  • Real World Evidence
  • Team Remap
  • Tendering & Procurement
  • Training
Content type
  • All
  • Articles
  • Case Study
  • Insider Insights
  • News
  • Newsletter
  • Publications
  • Webinar
Subscribe
Consent
This field is for validation purposes and should be left unchanged.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch